Vertex Readies For Major Readouts, With Data Due Soon In Big Pain Market

Phase II LSR Results For Suzetrigine Due By Year End

 
• By Mandy Jackson
  
Vertex may win two new drug approvals in the US in January (Shutterstock)

More from Earnings

More from Scrip